Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 2 |
2023 | 3 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
pickett l[au]
(71 results)?
PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors.
Oncoimmunology. 2022 Jun 18;11(1):2083755. doi: 10.1080/2162402X.2022.2083755. eCollection 2022.
Oncoimmunology. 2022.
PMID: 35756843
Free PMC article.
BET inhibition targets ABC-DLBCL constitutive B-cell receptor signaling through PAX5.
Oien DB, Sharma S, Hattersley MM, DuPont M, Criscione SW, Prickett L, Goeppert AU, Drew L, Yao Y, Zhang J, Chan HM.
Oien DB, et al. Among authors: prickett l.
Blood Adv. 2023 Sep 12;7(17):5108-5121. doi: 10.1182/bloodadvances.2022009257.
Blood Adv. 2023.
PMID: 37184294
Free PMC article.
Item in Clipboard
Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners.
Doshi AS, Cantin S, Hernandez M, Srinivasan S, Tentarelli S, Griffin M, Wang Y, Pop-Damkov P, Prickett LB, Kankkonen C, Shen M, Martin MS, Wu S, Castaldi MP, Ghadially H, Varnes J, Gales S, Henry D, Hoover C, Mele DA, Simpson I, Gangl ET, Mlynarski SN, Finlay MRV, Drew L, Fawell SE, Shao W, Schuller AG.
Doshi AS, et al. Among authors: prickett lb.
Mol Cancer Ther. 2023 May 4;22(5):630-645. doi: 10.1158/1535-7163.MCT-22-0431.
Mol Cancer Ther. 2023.
PMID: 36912782
Item in Clipboard
Systemic nano-delivery of low-dose STING agonist targeted to CD103+ dendritic cells for cancer immunotherapy.
Doshi AS, Cantin S, Prickett LB, Mele DA, Amiji M.
Doshi AS, et al. Among authors: prickett lb.
J Control Release. 2022 May;345:721-733. doi: 10.1016/j.jconrel.2022.03.054. Epub 2022 Apr 1.
J Control Release. 2022.
PMID: 35378213
Item in Clipboard
Age-induced changes in anti-tumor immunity alter the tumor immune infiltrate and impact response to immuno-oncology treatments.
Sitnikova SI, Walker JA, Prickett LB, Morrow M, Valge-Archer VE, Robinson MJ, Wilkinson RW, Dovedi SJ.
Sitnikova SI, et al. Among authors: prickett lb.
Front Immunol. 2023 Oct 18;14:1258291. doi: 10.3389/fimmu.2023.1258291. eCollection 2023.
Front Immunol. 2023.
PMID: 37920465
Free PMC article.
Item in Clipboard
Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell function including CD103+ dendritic cells enhancing anti-tumor immunity.
Borodovsky A, Barbon CM, Wang Y, Ye M, Prickett L, Chandra D, Shaw J, Deng N, Sachsenmeier K, Clarke JD, Linghu B, Brown GA, Brown J, Congreve M, Cheng RK, Dore AS, Hurrell E, Shao W, Woessner R, Reimer C, Drew L, Fawell S, Schuller AG, Mele DA.
Borodovsky A, et al. Among authors: prickett l.
J Immunother Cancer. 2020 Jul;8(2):e000417. doi: 10.1136/jitc-2019-000417.
J Immunother Cancer. 2020.
PMID: 32727810
Free PMC article.
Item in Clipboard
Cite
Cite